This blood test measures cholesterol and testosterone, both commonly assessed in relation to erectile function. It suits men noticing changes in sexual function who want an initial marker check before seeing a GP.
9 biomarkers as listed by Numan.
This panel combines a lipid profile (cholesterol, HDL, LDL, triglycerides, non-HDL cholesterol) with testosterone-related markers (total testosterone, FAI, SHBG). Cholesterol affects blood flow, and testosterone is commonly assessed in relation to sex drive and erectile function, so together they are commonly looked at as possible contributing factors when someone notices changes in sexual function. This test does not diagnose the cause of any symptoms; if you are concerned, it is worth discussing them with a GP alongside your results.
We do not have a matched set of directly competing tests for this specific combination of markers to compare it against by name. Against the wider set of men's health tests we track, it scores well on price for the number of markers covered.
Clinical depth scores well relative to other men's health tests we track, and clarity scores well too, since the marker list, sample type and turnaround are published plainly. Trust signals and results and follow-up both score well, the latter because a doctor reviews your results as standard.
This suits you if you have noticed changes in sexual function and want an initial check of cholesterol and testosterone before speaking to a GP, with a doctor reviewing your results as standard.
We do not have directly comparable competing tests logged for this exact combination to weigh it against on price. If you only want a testosterone reading rather than the combined panel, Numan's own Testosterone Blood Test covers five testosterone-related markers for £58.
You collect a finger-prick sample at home, or add £10 for a Tasso+ upper-arm device. Results are typically ready within 3 to 5 days of the sample reaching the lab, and a doctor reviews them as standard.
Numan's Sexual Performance Blood Test checks nine markers, cholesterol and testosterone measures, for £68. We do not have directly comparable competing tests logged for this exact combination, but its price scores well against similar men's health tests we track. Results are reviewed by a doctor as standard, and it is not a diagnostic test on its own.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
9 biomarkers, placing it in the 67th percentile of mens health tests we track.
A finger-prick sample you take at home; results in around 5 days, slower than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.6 from 35,911 reviews; accredited lab (UKAS ISO 15189 partner labs (Alderley Lighthouse, Randox)); CQC registered; doctor review as standard.
£68.00 against a median of £85.00 for the 5 similarly sized mens health tests we track (-20%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
One of the deepest men's health panels we track
A 21-marker blood test covering testosterone, cholesterol, liver health, inflammation and vitamin D, for men wanting a broad check on long-term health risk.
50-marker hormone and inflammation panel for skin concerns
A 50-marker blood panel covering hormones, thyroid, inflammation, iron, liver, kidney and vitamin levels that can influence skin condition. Suited to anyone investigating persistent skin issues such as breakouts or dryness.
PSA test priced at the group's £59 median
A single blood test measuring prostate specific antigen (PSA), a marker commonly used to help assess prostate cancer risk. Suited to men aged 45 and over, or 40 and over if at higher risk, as part of regular monitoring.
Cheaper than most PSA tests we track, but not the cheapest
Measures PSA, a protein produced by the prostate, commonly used to assess prostate health. Suited to those in a higher-risk group by age, ethnicity or family history.
